There are multiple treatment options for patients with low-risk prostate cancer: active surveillance, surgery, external beam radiotherapy and low-dose rate brachytherapy. There is no evidence to suggest a difference in survival outcomes for the various options. Therefore, patients must take into account the advantages and disadvantages of each treatment including the logistics, side effects and risks. Although doctors should provide information and advice, the patient must ultimately make their own informed decision. This can be incredibly difficult.